Synthesis of optically pure epibatidine analogs: (1R, 2R, 5S)-2β-(2-chloro-5-pyridinyl)-8-azabicyclo[3.2.1]octane and (1R, 2S, 5S)-2α-(2-chloro-5-pyridinyl)-8-azabicyclo[3.2.1]octane from (-)-cocaine

Tetrahedron Letters

Volumn 38, Issue 32, 1997, Pages 5619-5622

  Zhang, Chunming ^a   Gyermek, Laszlo ^b   Trudell, Mark L ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 5 PYRIDYL) 8 AZABICYCLO[3.2.1]OCTANE; COCAINE DERIVATIVE; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BINDING AFFINITY; CHIRALITY; CONTROLLED STUDY; DRUG PURITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ELECTRIC ORGAN; ENANTIOMER; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; REACTION ANALYSIS; STEREOCHEMISTRY; TORPEDO CALIFORNICA;

ANIMALIA; TORPEDO CALIFORNICA;

EID: 0030817954     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)01276-8     Document Type: Article

References (28)

1. Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; Yeh, H. J. C.; Pannell, L.; Daly, J. W. J. Am. Chem. Soc. 1992, 114, 3475-3478.
2. Li, T.; Qian, C.; Eckman, J.; Huang, D. F.; Shen, T. Y. Bioorg. Med. Lett. 1993, 3, 2579-2564.
3. Badio, B.; Daly, J. W. J. Mol. Pharmacol. 1994, 45, 563-569.
4. Qian, C.; Li, T.; Shen, T. Y.; Libertine-Garaham, L.; Eckman, J.; Biftu, T.; Ip, S. Eur. J. Pharmacol. 1993, 250, R13-R14.
5. For a recent review on 7-azabicyclo[2.2.1]heptanes see: Chen, Z.; Trudell, M. L. Chem. Rev. 1996, 96, 1179-1193.
6. For recent reviews on epibatidine see: (a) Broka, C. A. Med. Chem. Res. 1994, 4, 449-460.
7. (b) Szántay, C.; Kardos-Balogh, Z.; Szántay, C. Jr. The Alkaloids; Cordell, G. A. Ed.; Academic Press: San Diego. 1995, Vol. 46, pp. 95-125.
8. For recent syntheses of epibatidine and related compounds see: (a) Davis, C. R.; Johnson, R. A.; Ciadella, J. I.; Liggett, W. F.; Mizsak, S. A.; Marshall, V. P. J. Org. Chem. 1997, 62, 2244-2251.
9. (b) Albertini, E.; Barco, A.; Benetti, S.; De Risi, C.; Pollini, G. P.; Zanirato, V. Tetrahedron Lett. 1997, 38, 681-684.
10. (c) Szántay, C.; Kardos-Balogh, Z.; Moldvai, J.; Szántay, C. Jr.; Temesvari-Major, E.; Blasko, G. Tetrahedron 1996, 52, 11053-11062.
11. (d) Zhang, C.; Trudell, M. L. J. Org. Chem. 1996, 61, 7189-7191.
12. (e) Trost, B. M.; Cook, G. R. Tetrahedron Lett. 1996, 37, 7485-7488.
13. (f) Xu, R.; Chu, G.; Bai, D. Tetrahedron Lett. 1996, 37, 681-684.
14. (a) Xu, R.; Bai, D.; Chu, G.; Tao, J.; Zhu, X. Bioorg. Med. Chem. Lett. 1996, 6, 279-282.
15. (b) Bai, D.; Xu, R.; Chu, G.; Zhu, X. J. Org. Chem. 1996, 61, 4600-4606.
16. Malpass, J. R.; Hemmings, D. A.; Wallis, A. L. Tetrahedron Lett. 1996, 37, 3911-3914.
17. Zhang, C.; Lomenzo, S. A.; Ballay, C.; Trudell, M. L. J. Org. Chem.. 1997, (submitted).
18. Hama, Y.; Nobuhara, Y.; Aso, Y.; Otsubo, T.; Ogura, F. Bull. Chem. Soc. Jpn. 1988, 61, 1683-1686.
19. McMurry, J. E.; Scott, W. J. Tetrahedron Lett. 1983, 24, 979-983.
20. Tee, O. S.; Paventi, M. J. Am. Chem. Soc. 1982, 104, 4142-4146.
21. Shiao, M-J.; Shyu, L.-M.; Tarng, K.-Y.; Ma, Y.-T. Syn. Commun. 1990, 20, 2971-2977.
22. Smissman, E. E.; Makriyannis, A. J. Org. Chem. 1973, 38, 1652-1657.
23. + - Cl, 10).
24. In the 7-azabicyclo[2.2.1]heptane ring system, the endo-isomer can be epimerized to the eco-isomer. For examples see: (a) Fletcher, S. R.; Baker, R.; Chambers, M. S.; Hobbs, S. C.; Mitchell, P. J. J. Chem. Soc., Chem. Commun. 1993, 1216-1218.
25. (b) Kotian, P. L.; Carroll, F. I. Syn. Commun. 1995, 25, 63-71.
26. Okabe, K.; Natsume, M. Chem. Pharm. Bull. 1994, 42, 1432-1436.
27. Kanne, D. B.; Abood, L. G. J. Med. Chem. 1988, 31, 505-509.
28. Fisher, M.; Huangfu, D.; Shen, T. Y.; Guyenet, P. G. J. Pharmacol. Exp. Ther. 1994, 270, 702-707.